Healthcare · Research
Federated Clinical Trials
Multi-site clinical trials require sharing sensitive patient data across institutions, raising privacy and sovereignty concerns.
What stands in the way
How Scrydon solves it
How this plays out
A multi-site trial needs a large enough patient population to reach statistical significance, but pooling raw patient data across institutions raises exactly the privacy and sovereignty concerns that can stall a trial for months of legal review.
Data Spaces let each site keep its own patient data in place while contributing to federated model training, so the trial reaches the population it needs without a single record ever leaving the institution that holds it — accelerating development without a data-sharing agreement standing in the way.
- Accelerated drug development with full compliance to data protection regulations.
Prefer to write? Email hello [at] scrydon.com and we will get back to you.
Explore the rest
- Clinical Decision Support
- Healthcare Regulatory Reporting
- Patient Flow Optimisation
- Water Quality Monitoring
- Shadow AI Discovery for EU AI Act Readiness
- Unified Clinical Semantic Layer
- Clinical Data Catalog & Lineage for AI
- Human-Agent Care Coordination Workflows
- Ontology-Based Patient & Provider Master Data
- Crisis Supply Allocation & Distribution
- Elective Care Backlog Recovery